Enhancement to award-winning platform streamlines workflows and helps researchers across scientific disciplines bring knowledge and products to market more efficiently
Today, Wolters Kluwer, Health announced that it has entered into a multi-year agreement with the American College of Surgeons (ACS), a scientific and educational association of surgeons focused on improving the quality of care for the surgical patient. Wolters Kluwer will publish the Journal of the American College of Surgeons (JACS), ACS’s flagship clinical publication and one of the more highly cited surgery journals in the world with an impact factor of 6.113 and ranking 9/270 in the Surgery category, beginning in January 2022.
Chula Faculty members joined forces in dental materials science to develop easy-to-use “light-activated dental materials” that meet international standards and help shorten tooth filling time. The secret of these innovative dental materials, made by Thai people, is Acemannan polymer from Aloe Vera that can stimulate the formation of dentin and reduce tooth sensitivity in many dental health products.
Wolters Kluwer, Health announced a multi-year agreement reestablishing its collaboration with the Congress of Neurological Surgeons (CNS), the leading organization dedicated to advancing neurosurgery through education and innovation. Beginning in January 2022, Wolters Kluwer will publish three medical specialty journals from CNS’s portfolio including its flagship publication Neurosurgery, one of the most highly cited neurosurgery journals in the world.
Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.
To help clinicians stay current on orthopaedic and musculoskeletal research, Wolters Kluwer, Health announced today that Ovid® users will now have access to OrthoEvidence, a first of its kind evidence-based summary provider for orthopaedic specialists, surgeons, nurses, medical residents and students.
NEJM Group and Education Management Solutions (EMS), a Collegis Education company, have signed an agreement to put a cutting-edge clinical diagnosis training program in front of every healthcare student in the United States.
EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.
Thirty-three inventors from two colleges, six departments and three research centers at The University of Alabama in Huntsville (UAH), a part of the University of Alabama System, received award plaques for 21 patents at a virtual ceremony on Friday, April 16.
Corporations concerned with cultivating and recruiting the workforce of tomorrow due to the dramatic effects of COVID-19 on America’s youth are turning to CFES Brilliant Pathways for answers.
Wolters Kluwer, Health, a leading global provider of information and point-of-care solutions for the healthcare industry, is pleased to announce that it has been named publisher of American Journal of Medical Quality (AJMQ), the official journal of the American College of Medical Quality (ACMQ).
Rodeo Therapeutics Corp., a drug-development startup founded by two leading researchers from the Case Western Reserve University School of Medicine and a third scientific partner, has been sold to Amgen Inc., a publicly traded international biopharmaceutical company.
Under terms of the agreement, Amgen, based in Thousand Oaks, California, will acquire all outstanding shares of Rodeo for $55 million, plus “future contingent milestone payments potentially worth up to an additional $666 million in cash,” the companies announced today. Total consideration to Rodeo stakeholders could potentially be worth up to $721 million in cash.
GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Ambry Genetics®, a leading clinical genetic testing company, to integrate online genetic counseling and testing services into gastroenterology practices nationwide. This partnership addresses a critical clinical need for identifying hereditary GI cancer syndromes to help guide potentially life-altering health care decisions.
GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer the CARE (Comprehensive, Assessment, Risk, and Education) Program™ from Ambry Genetics.
RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of a third-party test that proves the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.96% of airborne SARS-CoV-2 virus.
La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates.
Case Western Reserve University’s HoloAnatomy® Software Suite will star this week in online events that Microsoft is hosting for colleges and universities-- Tuesday, Jan. 26, in a webinar titled “A New Vision for Medical Education” and Wednesday, Jan. 27, in Microsoft’s HoloLens Industry Summit, which will include an education break-out session.
Today, Wolters Kluwer, Health announced the publication of Cannabis: A Handbook for Nurses, the first medical cannabis book written specifically for nurses. The book addresses nursing skills and responsibilities in cannabis care, including the physiology of the human endocannabinoid system, cannabis care as it relates to specific disease processes, the history of cannabis, advocacy and ethics, and the ins and outs of cannabis dosing, delivery methods, side effects, and more.
Arthrex, a global leader in minimally invasive orthopedic technology, announced today the launch of the SwiveLock® ACL Repair Kit, following clearance by the U.S. Food and Drug Administration of the SwiveLock® anchor for ACL repair. It is the first and only FDA-cleared kit for the primary repair of anterior cruciate ligament (ACL) tears.
ALCEDIAG, one of 3 finalists for the “Disruptive Technology Award” at the annual AACC meeting 2020, will be holding a press conference to announce a game-changing technology and diagnostic tool for precision medicine in psychiatry: EDIT-BTM, the very first blood test for a high-performance differential diagnosis of unipolar depression and bipolar disorder.
AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.
Join us for an overview of MedSchenker’s product lines, including our Smart Transport Medium (STM™) and CavSwabs, among other innovations we introduced to the market this past year.
GenScript USA Inc., the world’s leading research reagent provider, announced today that Brazil's National Health Surveillance Agency (ANVISA) (Agência Nacional de Vigilância Sanitária) has authorized the use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit for detecting neutralizing antibodies. The cPass test is the first and only ANVISA authorized test for detecting neutralizing antibodies to SARS-CoV-2. Neutralizing antibodies specifically block the ability of a virus to infect a cell and are well-recognized to confer immunity.
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.
Aim Lab Automation Technologies pre-analytical and post analytical COVID-19 PathFinder benchtop automation solutions can help overcome many of these COVID-19 related challenges and reduce the risk of biohazards exposure to staff.
AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.
AACC is pleased to announce the recipients of the AACC 2020 Top Corporate Supporter Awards. This year, AACC recognizes 45 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
The Tube Decapper is an OEM Module designed for easy integration into any analyser or automation system to automate the decapping of specimen collection tubes.
Diamond Technologies is proud to announce the release of the new DE02 an industrial embedded barcode scan module for laboratory and medical devices as well as kiosks and automated machines.
Diamond Technologies is proud to announce the release of the new DE05 Industrial embedded barcode scan module for laboratory and medical devices as well as kiosks and automated machines.
The plasma volume status of a patient is one of the top priorities in evaluating and treating many different conditions including, shock, sepsis, congestive heart failure, acute or chronic kidney disease, chronic pulmonary disease, as well as general postoperative care.
The IFCC announces the IFCC Global Conference on COVID-19 that will take place virtually on February 15-17, 2021. The theme of this conference will be the “Critical Role of Clinical Laboratories in the COVID-19 Pandemic".
The IFCC Information Guide on COVID-19, initially published on 23 March 2020, is continuously updated. A Summary of the Guide in Spanish and Czech is also available.
Announcement of the 3 top winners, 9 teams of distinction, and 12 teams of achievement of the Awards programme. The 2020 submissions included hospitals, commercial laboratories, reference laboratories, clinics and rural community care.
The biennial EuroMedLab congresses bring together scientists, laboratory specialists, clinicians, and industry professionals in the field of laboratory medicine.
Worthington, the leading supplier of specialty enzymes for over 70 years, announces today the publication of an expanded, 2021-22 Enzyme and Biochemical Product Catalog. As a primary enzyme producer for biochemistry, cell biology, molecular biology, pre-clinical research and bioprocessing applications, Worthington is the “go-to” expert in enzyme technology.
Baebies has been named a finalist for the 2020 American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award for FINDER®, a near-patient testing platform. As a growth-stage company developing diagnostic products to provide a healthy start for children everywhere, Baebies FINDER tests for diseases from low blood volume (50 µL) with a turn-around time of approximately 15 minutes after sample introduction.
University of Warwick spin out company, Warwick Acoustics, have the ultimate gift for music enthusiasts seeking the most unforgettable and remarkable listening experience delivered in a one of kind, eye-catching, headphone system.
Eppendorf AG announces the release of its new Move It® Adjustable Spacing Pipettes. This new line of pipettes significantly reduces operating time when compared to single-channel pipettes, building efficiencies in laboratories.
Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)-designated cancer center in Washington state, has been selected as an authorized treatment center to offer brexucabtagene autoleucel, also known by the brand name TecartusTM. It is the first and only chimeric antigen receptor (CAR) T-cell therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).
Globus, a leading research data management service, reached a huge milestone by breaking the exabyte barrier. While it took over 2,000 days for the service to transfer the first 200 petabytes (PB) of data, the last 200PB were moved in just 247 days. This rapidly accelerating growth is reflected by the more than 150,000 registered users who have now transferred over 120 billion files using Globus.
TLL The Longevity Labs GmbH (Longevity Labs+), an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., are proud to announce their award for "The Most Innovative OTC-Product" at the German 2020 Pharma Trend Image & Innovation Awards in Munich, for their novel dietary supplement, spermidineLIFE®.
DENVER, Sept. 9, 2020 /PRNewswire/ -- TLL The Longevity Labs GmbH, an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., announce the market-launch of sales in the US of its award-winning dietary supplement, spermidineLIFE®. spermidineLIFE® is the world's first naturally extracted and clinically tested dietary supplement to promote cellular renewal. The active ingredient, spermidine, is considered key to slowing down the cellular aging process.
Mizuho OSI®, a leading manufacturer of specialty surgical tables and pressure injury abatement solutions is pleased to announce the acquisition of the Air Barrier System (ABS) from Nimbic Systems, Inc.
Dr. Jay Calvert, a Board Certified Plastic Surgeon from Beverly Hills, and his associate, Dr Millicent Rovelo, have published their experience with simultaneous revision rhinoplasty with rib cartilage harvest and breast Implant surgery.
The Donald Danforth Plant Science Center announced the lineup of TableTalks, a series of conversations shaping the future of food that will follow each AgTech NEXT conference session on Tuesdays, September 22 – November 10 from 1:30 – 2:15 PM.
Kimera® Labs Inc, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera's first-in-class XoGlo® isolated placental mesenchymal stem cell-based exosomes.